'Ebolanomics' - a Pharmaceutical Question

Monday, 19 January 2015 - 5:00pm to 6:15pm

The Ebola outbreak in West Africa has now claimed over 6,856 lives (15th December) with over 18,000 cases to date. The virus was discovered in 1976 but no vaccine for the disease is available. It has been suggested that there has been a lack of will to produce a vaccine largely due to Ebola outbreaks tending to occur in poorer countries and that consequently there is limited commercial viability and scope for profit.

Speakers include:
Dr. Adesina Iluyemi PhD, Executive Board Member, NEPAD Council
Dr. Egeruan Babatunde Imoukhuede, Clinical Vaccinologist & Project Manager, The Jenner Institute at Oxford University
Mr. Jon Pender, Vice President, Government Affairs, GlaxoSmithKline
Dr. Adrian Thomas, Vice President of Global Market Access & Head of Global Public Health, Janssen Pharmaceutical Companies of Johnson & Johnson

Venue Information: 

House of Commons
Committee Room 11
London SW1A 0AA

Organiser Contacts: 

baileyh@parliament.uk

No events to display in this section right now

Coming Up

No events to display in this section right now

Past Events

  • Award-winning UK Black Pride – Europe’s largest not-for-profit event for...

  • Creative weekly workshops for LGBT 18-30 year olds and 16-18 year olds from...

  • Rainbow! is an African-centred discussion and action group for LGBTQI...

  • The African Market showcases original fashion, accessories, jewellery,...

  • The African Market showcases original fashion, accessories, jewellery,...

  • Open the Gate is proudly hosting their unique alternative fair, The African...

More Testimonials